1558P Mitigating infusion-related reactions (IRRs) with cetirizine and montelukast in patients (pts) receiving REGN7075, an EGFR×CD28 bispecific antibody (bsAb).
Saved in:
| Title: | 1558P Mitigating infusion-related reactions (IRRs) with cetirizine and montelukast in patients (pts) receiving REGN7075, an EGFR×CD28 bispecific antibody (bsAb). |
|---|---|
| Authors: | Segal, N.H.1 (AUTHOR), Girda, E.2 (AUTHOR), Keenan, B.P.3 (AUTHOR), Hecht, J.R.4 (AUTHOR), Le, X.5 (AUTHOR), Johnson, M.L.6 (AUTHOR), Torres Jimenez, J.7 (AUTHOR), Gomez-Roca, C.A.8 (AUTHOR), Ghiringhelli, F.9 (AUTHOR), Ates, O.10 (AUTHOR), Moreno Garcia, V.11 (AUTHOR), Laux, D.12 (AUTHOR), Berz, D.13 (AUTHOR), Chen, R.14 (AUTHOR), Wang, J.15 (AUTHOR), Han, H.15 (AUTHOR), Mathias, M.D.15 (AUTHOR), Seebach, F.A.15 (AUTHOR), Kinnaman, M.D.15 (AUTHOR), Sohal, D.16 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS930-S930. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189419980 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1558P Mitigating infusion-related reactions (IRRs) with cetirizine and montelukast in patients (pts) receiving REGN7075, an EGFR×CD28 bispecific antibody (bsAb). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Segal%2C+N%2EH%2E%22">Segal, N.H.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Girda%2C+E%2E%22">Girda, E.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Keenan%2C+B%2EP%2E%22">Keenan, B.P.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hecht%2C+J%2ER%2E%22">Hecht, J.R.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Le%2C+X%2E%22">Le, X.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Johnson%2C+M%2EL%2E%22">Johnson, M.L.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Torres+Jimenez%2C+J%2E%22">Torres Jimenez, J.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gomez-Roca%2C+C%2EA%2E%22">Gomez-Roca, C.A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ghiringhelli%2C+F%2E%22">Ghiringhelli, F.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ates%2C+O%2E%22">Ates, O.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moreno+Garcia%2C+V%2E%22">Moreno Garcia, V.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Laux%2C+D%2E%22">Laux, D.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berz%2C+D%2E%22">Berz, D.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+R%2E%22">Chen, R.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+J%2E%22">Wang, J.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Han%2C+H%2E%22">Han, H.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mathias%2C+M%2ED%2E%22">Mathias, M.D.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Seebach%2C+F%2EA%2E%22">Seebach, F.A.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kinnaman%2C+M%2ED%2E%22">Kinnaman, M.D.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sohal%2C+D%2E%22">Sohal, D.</searchLink><relatesTo>16</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS930-S930. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419980 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.2188 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S930 Titles: – TitleFull: 1558P Mitigating infusion-related reactions (IRRs) with cetirizine and montelukast in patients (pts) receiving REGN7075, an EGFR×CD28 bispecific antibody (bsAb). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Segal, N.H. – PersonEntity: Name: NameFull: Girda, E. – PersonEntity: Name: NameFull: Keenan, B.P. – PersonEntity: Name: NameFull: Hecht, J.R. – PersonEntity: Name: NameFull: Le, X. – PersonEntity: Name: NameFull: Johnson, M.L. – PersonEntity: Name: NameFull: Torres Jimenez, J. – PersonEntity: Name: NameFull: Gomez-Roca, C.A. – PersonEntity: Name: NameFull: Ghiringhelli, F. – PersonEntity: Name: NameFull: Ates, O. – PersonEntity: Name: NameFull: Moreno Garcia, V. – PersonEntity: Name: NameFull: Laux, D. – PersonEntity: Name: NameFull: Berz, D. – PersonEntity: Name: NameFull: Chen, R. – PersonEntity: Name: NameFull: Wang, J. – PersonEntity: Name: NameFull: Han, H. – PersonEntity: Name: NameFull: Mathias, M.D. – PersonEntity: Name: NameFull: Seebach, F.A. – PersonEntity: Name: NameFull: Kinnaman, M.D. – PersonEntity: Name: NameFull: Sohal, D. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
